Stories
Madison startup developing chemical health testing platform
WID's Randolph Ashton is developing a method for “scalable and cost-effective screening” of various chemical compounds on the brain and spinal cord. The new company is Neurosetta.
How Does Life Begin?
PhD student Lena Vincent pursues the biggest question in her research on the chemical origins of life.
Achieving STEM diversity: Fix the classrooms
A perspective piece published on June 2 in Science from the Wisconsin Institute for Discovery (WID) suggests that outdated classroom teaching methods discourage members of historically excluded communities (HECs) from graduating with a degree in science. Lead author, Jo Handelsman states "Outdated classroom teaching models are discriminatory, ultimately, we need to stop trying to fix the students and instead focus on our classrooms."
New nanoparticles aid sepsis treatment in mice
In new research published today, UW–Madison WID researcher Shaoqin "Sarah" Gong, reported a new nanoparticle-based treatment for sepsis that delivers anti-inflammatory molecules and antibiotics.
Announcements
Newsletters
Follow Us
Learn more about the Wisconsin Institute for Discovery through quarterly newsletters and receive our annual report.
